BIO Other Stockholder Equity from 2010 to 2025
| BKYI Stock | USD 1.34 0.02 1.47% |
Other Stockholder Equity | First Reported 1996-12-31 | Previous Quarter 126.1 M | Current Value 128 M | Quarterly Volatility 36.1 M |
Check BIO Key financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIO Key's main balance sheet or income statement drivers, such as Depreciation And Amortization of 573.1 K, Interest Expense of 186.6 K or Selling General Administrative of 5.1 M, as well as many indicators such as Price To Sales Ratio of 0.24, Dividend Yield of 0.0028 or PTB Ratio of 1.49. BIO financial statements analysis is a perfect complement when working with BIO Key Valuation or Volatility modules.
BIO | Other Stockholder Equity |
Latest BIO Key's Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of BIO Key International over the last few years. It is BIO Key's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BIO Key's overall financial position and show how it may be relating to other accounts over time.
| Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
| Timeline |
BIO Other Stockholder Equity Regression Statistics
| Arithmetic Mean | 88,417,493 | |
| Geometric Mean | 65,848,877 | |
| Coefficient Of Variation | 45.65 | |
| Mean Deviation | 31,845,543 | |
| Median | 86,289,592 | |
| Standard Deviation | 40,362,804 | |
| Sample Variance | 1629.2T | |
| Range | 151.4M | |
| R-Value | 0.97 | |
| Mean Square Error | 112.3T | |
| R-Squared | 0.94 | |
| Slope | 8,200,562 | |
| Total Sum of Squares | 24437.3T |
BIO Other Stockholder Equity History
About BIO Key Financial Statements
Investors use fundamental indicators, such as BIO Key's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although BIO Key's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Other Stockholder Equity | 145 M | 152.2 M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out the analysis of BIO Key Correlation against competitors. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.